US Patent 7662813 Triazole compounds that modulate HSP90 activity
Patent 7662813 was granted and assigned to Synta Pharmaceuticals on February, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 17, 2006
Date of Patent
February 16, 2010
Patent Application Number
11506185
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7662813 Triazole compounds that modulate HSP90 activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
